Want to see HSIC full AI Analyst Report?
HSIC Stock Chart & Stats
$85.47
-$0.86(-1.01%)
At close: 4:00 PM EDT
$85.47
-$0.86(-1.01%)
Day’s Range― - ―
52-Week Range$61.95 - $89.34
Previous Close$84.61
Volume1.49M
Average Volume (3M)1.28M
Market Cap
$9.76B
Enterprise Value$13.54K
Total Cash (Recent Filing)$138.00M
Total Debt (Recent Filing)$3.75B
Price to Earnings (P/E)25.7
Beta0.32
Next Earnings
Aug 04, 2026EPS Estimate
1.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.34
Shares Outstanding113,916,756
10 Day Avg. Volume1,389,561
30 Day Avg. Volume1,278,409
Financial Highlights & Ratios
PEG Ratio3.23
Price to Book (P/B)2.83
Price to Sales (P/S)0.70
P/FCF Ratio16.05
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$86.92Price Target Upside1.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)5.35
Revenue Forecast (FY)$13.75B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables & Services MixHenry Schein’s core model centers on high-frequency consumables plus equipment and practice-facing services, creating steady reorder economics and cross-sell opportunities. This recurring mix supports predictable revenue, customer stickiness and long-term margin resilience versus one-off transactional models.
Cloud And Software Subscription MomentumRapid subscription growth in cloud software increases recurring, higher-margin revenue and deepens practice-level integration. Software adoption boosts lifetime value, reduces churn risk, and enables scalable upsell of services and supplies, structurally shifting mix toward steadier, higher-margin streams.
Clear Multi-year Value-creation PlanA defined cost and margin program with quantified targets signals management discipline and potential structural margin recovery. Realized savings (procurement, back-office outsourcings, value pricing) can sustainably improve operating leverage and cash generation if execution persists beyond the initial reform period.
Bears Say
Elevated LeverageMaterial increase in leverage reduces financial flexibility and raises refinancing and covenant risk if cash generation softens. Achieving returns with higher debt amplifies downside volatility, limits strategic optionality (M&A, opportunistic investment) and increases sensitivity to rate or margin shocks over the medium term.
Net Margin CompressionStructural profit erosion reflects mix shifts, pricing pressure in digital equipment and implant mix headwinds. Even with stable gross margins, lower operating and net margins constrain cash flow and reinvestment capacity, making long-term profitability more dependent on successful cost initiatives and higher-margin service growth.
Weakened Free Cash Flow And Cash VolatilityDeclining free cash flow and seasonal operating cash volatility reduce the buffer to fund buybacks, debt paydowns and capex. Lower and less predictable cash conversion increases reliance on debt markets or cuts to discretionary investment if margins underperform or restructuring costs persist, elevating medium-term risk.
Henry Schein News
HSIC FAQ
What was Henry Schein’s price range in the past 12 months?
Henry Schein lowest stock price was $61.95 and its highest was $89.34 in the past 12 months.
What is Henry Schein’s market cap?
Henry Schein’s market cap is $9.76B.
When is Henry Schein’s upcoming earnings report date?
Henry Schein’s upcoming earnings report date is Aug 04, 2026 which is in 5 days.
How were Henry Schein’s earnings last quarter?
Henry Schein released its earnings results on May 05, 2026. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.218 by $0.102.
Is Henry Schein overvalued?
According to Wall Street analysts Henry Schein’s price is currently Undervalued.
Does Henry Schein pay dividends?
Henry Schein does not currently pay dividends.
What is Henry Schein’s EPS estimate?
Henry Schein’s EPS estimate is 1.24.
How many shares outstanding does Henry Schein have?
Henry Schein has 113,916,756 shares outstanding.
What happened to Henry Schein’s price movement after its last earnings report?
Henry Schein reported an EPS of $1.32 in its last earnings report, beating expectations of $1.218. Following the earnings report the stock price went up 3.263%.
Which hedge fund is a major shareholder of Henry Schein?
Currently, no hedge funds are holding shares in HSIC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Henry Schein Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$86.92 (1.69% Upside)
$86.92 (1.69% Upside)
Blogger Sentiment
Bullish
HSIC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 170.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $691.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.19%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
7.86%
Trailing 12-Months
Company Description
Henry Schein
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
HSIC Company Deck
HSIC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong operational and financial positives — solid revenue growth (+6.3% total, 2.5% internal), non-GAAP margin expansion (+28 bps), adjusted EBITDA growth (+11.6%), cloud/customer momentum (+25% cloud subscribers), rapid e-commerce adoption (80%+ U.S. dental e-commerce), and an explicit multi-year value-creation plan with a $125 million 2026 run-rate target and a >$200 million longer-term target. Offsetting these were manageable but important risks: a Q1 GAAP margin dip and slight GAAP net income decline, negative Q1 operating cash flow (seasonal), softness in medical diagnostics due to a light flu season, digital equipment ASP pressure, restructuring costs ($12M in Q1), and exposure to rising oil/freight costs. Overall, the positives (growth, margin expansion on a non-GAAP basis, technology and e-commerce traction, and clear cost-transformation initiatives) materially outweigh the near-term headwinds and execution costs, supporting an optimistic outlook grounded with prudent caveats around macro and timing of savings.View all HSIC earnings summariesHSIC Revenue Breakdown
84.48% Global Distribution and Value-Added Services
11.71% Global Specialty Products
5.12% Global Technology
-1.31% Eliminations
HSIC Stock 12 Month Forecast
Average Price Target
$86.92
▲(1.69% Upside)
Technical Analysis
Ownership Overview
1.33% Insiders
29.09% Mutual Funds
0.42% Other Institutional Investors
45.61% Public Companies and
Individual Investors